Attached files
file | filename |
---|---|
EX-10.9 - EX-10.9 - Spero Therapeutics, Inc. | spro-ex109_1873.htm |
EX-32.2 - EX-32.2 - Spero Therapeutics, Inc. | spro-ex322_9.htm |
EX-32.1 - EX-32.1 - Spero Therapeutics, Inc. | spro-ex321_8.htm |
EX-31.2 - EX-31.2 - Spero Therapeutics, Inc. | spro-ex312_7.htm |
EX-31.1 - EX-31.1 - Spero Therapeutics, Inc. | spro-ex311_6.htm |
EX-23.1 - EX-23.1 - Spero Therapeutics, Inc. | spro-ex231_1098.htm |
10-K - 10-K - Spero Therapeutics, Inc. | spro-10k_20171231.htm |
Exhibit 21.1
SUBSIDIARIES OF SPERO THERAPEUTICS, INC.
|
|
|
Subsidiary |
|
Jurisdiction |
New Pharma License Holdings |
|
Malta |
Spero Cantab, Inc. |
|
Delaware |
Spero Cantab UK Limited |
|
England and Wales |
Spero Europe, Ltd. |
|
England and Wales |
Spero Gyrase, Inc. |
|
Delaware |
Spero Legacy STI, Inc. |
|
Delaware |
Spero Potentiator, Inc. |
|
Delaware |
Spero Potentiator PTY LTD |
|
Australia |
Spero Securities Corporation |
|
Massachusetts |